Wound Healing in Hidradenitis Suppurativa
- 35 Downloads
Hidradenitis suppurativa (HS) is a chronic, debilitating disease that is challenging to treat. It presents with recurrent nodules and tunnels that often drain. The exudate, pain, and odor associated with these lesions can impose a significant psychosocial burden on patients. As a result, optimal wound care is an important adjunct to the medical and/or surgical therapy for these patients. The wound care framework for patients with HS is similar to general wound care. The algorithm employed for HS wound care starts with first classifying wounds as post-surgical or non-surgical. For post-surgical wounds, it is important to determine whether the wound is simple or complex, whereas for non-surgical wounds, determining the amount of exudate and the presence of infection is essential in choosing the ideal dressing. Ultimately, it is of utmost importance to educate the patient on the kind of wound care their disease necessitates and to understand what barriers a patient may face in adhering to optimal wound care.
KeywordsHidradenitis suppurativa Wound care Biofilms Hurley stage Foam dressings Gelling fibers Calcium alginate Non-adherent dressings Gel-based dressings Dressings with antiseptics Negative pressure wound therapies Cellular skin substitutes Acellular skin substitutes
Incision and drainage
Negative pressure wound therapy
Conflict of Interest
AA has consulted for AbbVie, Janssen, LEO, Galderma, Novartis, and Valeant and is also an investigator for AbbVie, Novartis, Regeneron, Pfizer, Boehringer-Ingelheim, Glenmark, Merck Serono, Roche, Xoma, and Xenon. AA received an unrestricted educational grant from AbbVie.
MAL has consulted for AbbVie, Incyte, Janssen, BSN, and Xbiotech.
All authors state no conflict related to this manuscript.
- 13.Nelson A. Extracellular traps and matrix metalloproteases are components of the invasive proliferative gelatinous mass in hidradenitis suppurativa. Symposium on Hidradenitis Suppurativa Advances; October 13, 2018; Toronto; 2018.Google Scholar
- 15.Naik HB, Nassif A, Ramesh M, Schultz G, Piguet V, Alavi A, et al. Are bacteria infectious pathogens in hidradenitis suppurativa (HS)?. J Invest Dermatol. 2019;139(1):13–6.Google Scholar
- 18.Bredow J, Oppermann J, Hoffmann K, Hellmich M, Wenk B, Simons M, et al. Clinical trial to evaluate the performance of a flexible self-adherent absorbent dressing coated with a soft silicone layer compared to a standard wound dressing after orthopedic or spinal surgery: study protocol for a randomized controlled trial. Trials. 2015;16(1):81.CrossRefGoogle Scholar
- 19.Stéphane P, Maxime C, Alexandre D, Jolène P. Reduction of tape blisters after hip surgery – a prospective evaluation of three kinds of bandages. Orthop Proceed. 2012;94-B(SUPP_XXXVIII):164.Google Scholar
- 24.Pandey RK, Jalde DD, Godhi SA, Godhi AS. A randomized control trial to assess the efficacy of calcium alginate dressing versus conventional gauze dressing on bacterial load in infected diabetic foot ulcer. 2011. 126–130 p.Google Scholar
- 31.Vig K, Chaudhari A, Tripathi S, Dixit S, Sahu R, Pillai S, et al. Advances in skin regeneration using tissue engineering. Int J Mol Sci. 2017;18(4).Google Scholar